CMRC
Commerce.com, Inc.
CMRC's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over CMRC overall, supported by stronger valuation and stronger modeled upside.
CMRC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Weak |
CMRC's revenue, profitability and cash flow are currently stable, but its balance sheet is weak.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
CMRC PE Valuation
CMRC has no meaningful PE right now: it lost money over the past year.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
CMRC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CMRC's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
CMRC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.57 | — |
| Q3 2026 | -$0.09 | +$0.07 |
| Q2 2026 | -$0.08 | +$0.14 |
| Q1 2026 | -$0.19 | +$0.08 |
| Q4 2025 | -$0.24 | +$0.11 |
| Q3 2025 | -$0.16 | +$0.20 |
| Q2 2025 | -$0.22 | +$0.32 |
| Q1 2025 | -$0.27 | +$0.37 |
| Q4 2024 | -$0.35 | +$0.51 |
CMRC is still losing money, but far less than before: $0.09 per share over the past year, against $1.95 at its worst in late 2022.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over CMRC on earnings quality, reporting a profit while its opponent remains loss making.
CMRC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $84.2M | -2.1% |
| Q2 2026 | $84.5M | +0.1% |
| Q1 2026 | $86.8M | +5.4% |
| Q4 2025 | $89.5M | +2.9% |
| Q3 2025 | $86M | +2.8% |
| Q2 2025 | $84.4M | +3.2% |
| Q1 2025 | $82.4M | +2.5% |
| Q4 2024 | $87M | +3.4% |
CMRC's revenue grew through 2024 and has held roughly level since: $84M last quarter, down 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -2.1% | -1.6 points |
| Q2 2026 | 3.2% | +11 points |
| Q1 2026 | 6.6% | +9.6 points |
| Q4 2025 | -7.4% | -6.5 points |
| Q3 2025 | -0.5% | +22 points |
| Q2 2025 | -8% | +8.4 points |
| Q1 2025 | -2.9% | +7.3 points |
| Q4 2024 | -0.9% | +5.9 points |
CMRC's operating margin was −2.1% last quarter, down 1.6 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over CMRC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over CMRC on profitability, with a higher operating margin.
CMRC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.7M | -24% |
| Q2 2026 | $50K | -100% |
| Q1 2026 | $14.1M | +$14.5M |
| Q3 2025 | $7.6M | +36% |
| Q2 2025 | $11.9M | +1.4% |
| Q1 2025 | -$424K | +$3M |
| Q3 2024 | $5.6M | +$37M |
| Q2 2024 | $11.7M | -20% |
CMRC has burned cash in most quarters: $18M over the past year, down 28% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over CMRC on cash flow, with more consistent year-over-year improvement.
CMRC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +164K shares |
| 1 year | +2.7% | +2.2M shares |
| 3 years | +10% | +7.6M shares |
| 5 years | +16% | +11.6M shares |
| Available history | +46% | +26.1M shares |
CMRC has 83M diluted shares, up 2.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2020 | — |
| Q4 2019 | — |
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over CMRC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
CMRC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.2x | High |
| Q2 2026 | 7.7x | High |
| Q1 2026 | 23.6x | High |
| Q3 2025 | 28.3x | High |
CMRC's net debt is about 5.2 years of its operating earnings (EBITDA).
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over CMRC on leverage, with a lower net debt burden relative to earnings.
CMRC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.5 | Neutral |
| Stochastic | 74.5 | Neutral |
CMRC's weekly RSI is 57 (neutral) and its Stochastic is 74 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CMRC PE vs Technology Sector
CMRC has no meaningful PE right now: it lost money over the past year.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
CMRC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.43 | 3.2% above |
| 20 week MA | $3.06 | 16% above |
| 50 week MA | $3.13 | 13% above |
| 100 week MA | $4.21 | 16% below |
| 200 week MA | $6.25 | 43% below |
CMRC has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
CMRC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $79.0 | $72.8 | -7.8% |
| 2021 | $72.8 | $38.5 | -47% |
| 2022 | $38.5 | $8.34 | -78% |
| 2023 | $8.34 | $9.73 | +17% |
| 2024 | $9.73 | $6.13 | -37% |
| 2025 | $6.13 | $4.19 | -32% |
| 2026 YTD | $4.19 | $3.54 | -16% |
CMRC has finished lower in five of the last six years. It's down 16% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over CMRC on returns for 2026, with the stronger performance.